Study of the role of hyperimmunity in half-headache

Not Applicable

• Conditions: Health Condition 1: G894- Chronic pain syndrome

• Registration Number: CTRI/2022/08/044685
• Lead Sponsor: Sri Ramachandra Institute of Higher Education and Research D

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Migraine with aura and without aura patients

2. Patients between 18 to 60 years old

3. Patients affected by COVID-19

4. Patients with other autoimmune disorder

Exclusion Criteria

1. Migraine patients with other comorbid diseases

2. Patients who had not taken any medications for migraine

3. Pregnant and lactating women

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
This study will compare the levels of autoantibodies in migraine patients with those of healthy volunteers in order to determine whether immunological malfunction may be the cause of migraine attacks.Timepoint: Investigation of 6 months

Secondary Outcome Measures

Name	Time	Method
This study will detect the autoantibody levels in migraine patients and will help in better understanding of migraine as an autoimmune disorderTimepoint: Investigation of 1 year